Brainstorm Cell Therapeutics upgraded by Maxim Group with a new price target

2/4/21 1:51:23 PM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Maxim Group upgraded Brainstorm Cell Therapeutics from Hold to Buy and set a new price target of $12.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BCLI

Date	Price Target	Rating	Analyst